Neutropenia
Neutropenia is a condition where you have a lower than normal number of neutrophils, which are crucial for fighting off infections. This can lead to increased susceptibility to infections and may require monitoring and treatment.
Neutropenia: Mavorixafor Study
We are investigating a new medication, mavorixafor, for people with neutropenia who have frequent infections. The study will assess how well it works and its safety compared to a placebo.
1-2 years6-10 visitsConfirmation phase (III)Post-Trial Drug AccessCost ReimbursementPartially RemoteInvestigational MedicinesOralHematologyInfectious DiseasesInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 12 years old?
- Do you weigh at least 15 kg (about 33 lbs)?
- Are you currently pregnant or breastfeeding?
- Have you had any serious infections that required antibiotics in the last year?
- Do you have a history of cancer in the last 5 years?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Mavorixafor
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Leuven
Pediatric Immunodeficiencies
Heverlee, Belgium
Fakultni Nemocnice Brno
Oddělení dětské hematologie a biochemie
Brno, Czechia
Fakultni Nemocnice V Motole
Klinika dětské hematologie a onkologie
Stodůlky, Czechia
Sponsor: X4 Pharmaceuticals Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.